XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   92,112,749    
Beginning balance at Dec. 31, 2022 $ 334,046 $ 92 $ 706,407 $ (372,453)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 11,612   11,612  
Issuance of common stock upon restricted stock unit vesting (in shares)   292,591    
Issuance of common stock upon restricted stock unit vesting 0      
Exercised stock options (in shares)   459,401    
Exercised stock options 1,416 $ 1 1,415  
Payments for taxes related to net settlement of equity awards (1,984)   (1,984)  
Net loss (16,963)     (16,963)
Ending balance (in shares) at Mar. 31, 2023   92,864,741    
Ending balance at Mar. 31, 2023 328,127 $ 93 717,450 (389,416)
Beginning balance (in shares) at Dec. 31, 2023   96,722,098    
Beginning balance at Dec. 31, 2023 324,941 $ 97 760,210 (435,366)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 13,906   13,906  
Issuance of common stock upon restricted stock unit vesting (in shares)   483,517    
Issuance of common stock upon restricted stock unit vesting 0 $ 1 (1)  
Exercised stock options (in shares)   309,868    
Exercised stock options 1,171 $ 0 1,171  
Payments for taxes related to net settlement of equity awards (5,678)   (5,678)  
Net loss (11,433)     (11,433)
Ending balance (in shares) at Mar. 31, 2024   97,515,483    
Ending balance at Mar. 31, 2024 $ 322,907 $ 98 $ 769,608 $ (446,799)